One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes.
Study Goal
The researchers aimed to compare the effects of high-carbohydrate (CHO) and high-monounsaturated fatty acid (MUFA) diets on body weight and glycemic control in individuals with type 2 diabetes.
Results Summary
The high-CHO diet resulted in similar weight loss, improvements in body composition, cardiovascular risk factors, and glycemic control compared to the high-MUFA diet, with no significant differences between the groups. These benefits were maintained in a subset of participants during an 18-month follow-up.
Population
Overweight/obese adults with type 2 diabetes (n = 124, age 56.5 ± 0.8 years, BMI 35.9 ± 0.3 kg/m², A1C 7.3 ± 0.1%).
Effective Dosage
Not specified
Duration
12 months (with an 18-month follow-up for a subset)
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
high-monounsaturated fatty acid (MUFA) diet | decrease | body weight | men and women with type 2 diabetes | - | comparable beneficial effects | #1 |
high-monounsaturated fatty acid (MUFA) diet | improvement | glycemic control | men and women with type 2 diabetes | - | comparable beneficial effects | #2 |
high-MUFA diet | decrease | body weight | overweight/obese participants with type 2 diabetes | -4.0 +/- 0.8 kg | similar weight loss | #3 |
high-CHO diet | decrease | body weight | overweight/obese participants with type 2 diabetes | -3.8 +/- 0.6 kg | similar weight loss | #4 |
high-MUFA diet | decrease | body fat | overweight/obese participants with type 2 diabetes | - | comparable improvement | #5 |
high-MUFA diet | decrease | waist circumference | overweight/obese participants with type 2 diabetes | - | comparable improvement | #6 |
high-MUFA diet | decrease | diastolic blood pressure | overweight/obese participants with type 2 diabetes | - | comparable improvement | #7 |
high-MUFA diet | increase | HDL cholesterol | overweight/obese participants with type 2 diabetes | - | comparable improvement | #8 |
high-MUFA diet | decrease | A1C | overweight/obese participants with type 2 diabetes | - | comparable improvement | #9 |
high-MUFA diet | decrease | fasting glucose | overweight/obese participants with type 2 diabetes | - | comparable improvement | #10 |
high-MUFA diet | decrease | fasting insulin | overweight/obese participants with type 2 diabetes | - | comparable improvement | #11 |
high-MUFA diet | no change | weight loss | subset of participants | - | maintained | #12 |
high-MUFA diet | no change | A1C | subset of participants | - | maintained | #13 |
high-MUFA diet | improvement | body composition | individuals with type 2 diabetes | - | comparable beneficial effects | #14 |
high-MUFA diet | improvement | cardiovascular risk factors | individuals with type 2 diabetes | - | comparable beneficial effects | #15 |
OBJECTIVE: The purpose of this study was to compare the effects of high-monounsaturated fatty acid (MUFA) and high-carbohydrate (CHO) diets on body weight and glycemic control in men and women with type 2 diabetes. RESEARCH DESIGN AND METHODS: Overweight/obese participants with type 2 diabetes (n = 124, age = 56.5 +/- 0.8 years, BMI = 35.9 +/- 0.3 kg/m2, and A1C = 7.3 +/- 0.1%) were randomly assigned to 1 year of a high-MUFA or high-CHO diet. Anthropometric and metabolic parameters were assessed at baseline and after 4, 8, and 12 months of dieting. RESULTS: Baseline characteristics were similar between the treatment groups. The overall retention rate for 1 year was 77% (69% for the high-MUFA group and 84% for the high-CHO group; P = 0.06). Based on food records, both groups had similar energy intake but a significant difference in MUFA intake. Both groups had similar weight loss over 1 year (-4.0 +/- 0.8 vs. -3.8 +/- 0.6 kg) and comparable improvement in body fat, waist circumference, diastolic blood pressure, HDL cholesterol, A1C, and fasting glucose and insulin. There were no differences in these parameters between the groups. A follow-up assessment of a subset of participants (n = 36) was conducted 18 months after completion of the 52-week diet. These participants maintained their weight loss and A1C during the follow-up period. CONCLUSIONS: In individuals with type 2 diabetes, high-MUFA diets are an alternative to conventional lower-fat, high-CHO diets with comparable beneficial effects on body weight, body composition, cardiovascular risk factors, and glycemic control.